BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 30485258)

  • 41. Traveling to Receive Treatment for Extremity Soft Tissue Sarcomas: Is it worth the drive?
    Vidri RJ; Raut CP; Fitzgerald TL
    World J Surg; 2021 Aug; 45(8):2415-2425. PubMed ID: 33891137
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Localized extremity soft tissue sarcoma: improved knowledge with unchanged survival over time.
    Weitz J; Antonescu CR; Brennan MF
    J Clin Oncol; 2003 Jul; 21(14):2719-25. PubMed ID: 12860950
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Local recurrence of soft tissue sarcoma. A Scandinavian Sarcoma Group Project.
    Trovik CS;
    Acta Orthop Scand Suppl; 2001 Feb; 72(300):1-31. PubMed ID: 11381580
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Survival in primary soft tissue sarcoma of the extremities and trunk.
    Peiper M; Zurakowski D; Zornig C
    Langenbecks Arch Chir; 1997; 382(4):203-8. PubMed ID: 9396000
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial.
    Judson I; Verweij J; Gelderblom H; Hartmann JT; Schöffski P; Blay JY; Kerst JM; Sufliarsky J; Whelan J; Hohenberger P; Krarup-Hansen A; Alcindor T; Marreaud S; Litière S; Hermans C; Fisher C; Hogendoorn PC; dei Tos AP; van der Graaf WT;
    Lancet Oncol; 2014 Apr; 15(4):415-23. PubMed ID: 24618336
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Does Advanced Imaging Have a Role in Detecting Local Recurrence of Soft-tissue Sarcoma?
    England P; Hong Z; Rhea L; Hirbe A; McDonald D; Cipriano C
    Clin Orthop Relat Res; 2020 Dec; 478(12):2812-2820. PubMed ID: 32667755
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chest wall resection for adult soft tissue sarcomas and chondrosarcomas: analysis of prognostic factors.
    van Geel AN; Wouters MW; Lans TE; Schmitz PI; Verhoef C
    World J Surg; 2011 Jan; 35(1):63-9. PubMed ID: 20857106
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Should soft tissue sarcomas be treated at high-volume centers? An analysis of 4205 patients.
    Gutierrez JC; Perez EA; Moffat FL; Livingstone AS; Franceschi D; Koniaris LG
    Ann Surg; 2007 Jun; 245(6):952-8. PubMed ID: 17522521
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Surgical margins and reresection in the management of patients with soft tissue sarcoma using conservative surgery and radiation therapy.
    Zagars GK; Ballo MT; Pisters PW; Pollock RE; Patel SR; Benjamin RS
    Cancer; 2003 May; 97(10):2544-53. PubMed ID: 12733154
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential impacts of initial treatment status on long-term survival in patients with sarcomas treated in a referral center according to histologic type and anatomic site.
    Chung YL; Huang TT; Chen CF
    Eur J Surg Oncol; 2023 Sep; 49(9):106927. PubMed ID: 37149404
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic factors and impact of surgery in patients with metastatic soft tissue sarcoma at diagnosis: A population-based cohort study.
    Zhang L; Akiyama T; Fukushima T; Iwata S; Tsuda Y; Takeshita K; Kawai A; Tanaka S; Kobayashi H
    Jpn J Clin Oncol; 2021 May; 51(6):918-926. PubMed ID: 33774673
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic factors for local recurrence and survival in patients with localized extremity soft-tissue sarcoma.
    Collin CF; Friedrich C; Godbold J; Hajdu S; Brennan MF
    Semin Surg Oncol; 1988; 4(1):30-7. PubMed ID: 3353622
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Patients with an increased time to treatment initiation have a poorer overall survival after definitive surgery for localized high-grade soft-tissue sarcoma in the extremity or trunk : report from the National Cancer Database.
    Ogura K; Fujiwara T; Healey JH
    Bone Joint J; 2021 Jun; 103-B(6):1142-1149. PubMed ID: 34058874
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identifying the Minimum Volume Threshold for Retroperitoneal Soft Tissue Sarcoma Resection: Merging National Data with Consensus Expert Opinion.
    Villano AM; Zeymo A; Chan KS; Shara N; Al-Refaie WB
    J Am Coll Surg; 2020 Jan; 230(1):151-160.e2. PubMed ID: 31672672
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High neutrophil-lymphocyte ratio is not independently associated with worse survival or recurrence in patients with extremity soft tissue sarcoma.
    Strong EA; Park SH; Ethun CG; Chow B; King D; Bedi M; Charlson J; Mogal H; Tsai S; Christians K; Tran TB; Poultsides G; Grignol V; Howard JH; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Cullinan D; Fields RC; Gamblin TC; Cardona K; Clarke CN
    Surgery; 2020 Oct; 168(4):760-767. PubMed ID: 32736869
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The prognostic significance of margin width for extremity and trunk sarcoma.
    McKee MD; Liu DF; Brooks JJ; Gibbs JF; Driscoll DL; Kraybill WG
    J Surg Oncol; 2004 Feb; 85(2):68-76. PubMed ID: 14755506
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Radiation therapy for high grade soft tissue sarcomas of the extremities treated with limb-preserving surgery.
    Karakousis CP; Zografos GC
    Eur J Surg Oncol; 2002 Jun; 28(4):431-6. PubMed ID: 12099655
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Referral patterns between high- and low-volume centers and associations with uterine cancer treatment and survival: a population-based study of Medicare, Medicaid, and privately insured women.
    Doll KM; Meng K; Gehrig PA; Brewster WR; Meyer AM
    Am J Obstet Gynecol; 2016 Oct; 215(4):447.e1-447.e13. PubMed ID: 27130238
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Current situation of soft tissue sarcomas: Registry of a Latin American cancer institute.
    Chávez M; Ziegler G; Cotrina J; Galarreta J; de la Cruz M; Mantilla R
    Cir Esp (Engl Ed); 2019 Apr; 97(4):203-212. PubMed ID: 30777256
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Impact of Academic Facility Type and Case Volume on Survival in Patients Undergoing Curative Radiation Therapy for Muscle-Invasive Bladder Cancer.
    Bajaj A; Martin B; Bhasin R; Hentz C; Block AM; Harkenrider MM; Solanki AA
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):851-857. PubMed ID: 29485062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.